Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Headlines > Syngenta acquires genetic repository from Novartis to boost biologic crop protection

Headlines

Syngenta acquires genetic repository from Novartis to boost biologic crop protection

Published by Global Banking and Finance Review

Posted on February 26, 2025

Featured image for article about Headlines

FRANKFURT (Reuters) - Switzerland-based pesticides maker Syngenta said on Wednesday that it has acquired a repository of natural compounds and genetic strains from drugmaker Novartis to further boost development of biologic crop protection.

In its statement, China-controlled Syngenta said that Novartis will retain exclusive rights to the repository for pharmaceutical use, without disclosing financial terms.

Under the deal, Syngenta will lease a fermentation pilot plant and science laboratories in Basel as well as hire a team of biomolecular chemistry researchers at Novartis.

Syngenta has been investing to develop organisms, natural molecules, plant extracts, and other bio-based materials to complement its chemical crop protection products.

(Reporting by Ludwig Burger, Editing by Miranda Murray)

More from Headlines

Explore more articles in the Headlines category

Sweeping US defense bill passes, with Ukraine, Venezuela provisions defying Trump

Sarajevo takes steps on air quality after most-polluted city ranking

Slovakia's top court pauses government overhaul of whistleblower agency

Brazil threatens to abandon Mercosur-EU deal as Italy, France seek delay

EU rules out UK exemption from carbon border levy until markets link

Poland prioritises domestic arms purchases under EU SAFE programme

G7 condemns prosecution of Jimmy Lai, calls for his release

UK's Inocea Group eyes acquisition of Germany warship builder GNYK, source says

US allows oil sales from Russia's Sakhalin-2 project through June 18

UK exempts Egypt's Zohr gas field from Russia sanctions

ECB proposes extending Elderson's mandate at bank supervision arm

Exclusive-Poland to start producing anti-personnel mines to lay along eastern border

View All Headlines Posts